Literature DB >> 2835402

Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.

A Girling1, M Caleffi, R J King, R R Millis.   

Abstract

Patterns of staining with a monoclonal antibody which recognises D5 antigen (a 29,000 kD oestrogen receptor-related protein) were studied in seven normal and 76 benign breast biopsy specimens as well as in 12 cases of pure in situ mammary carcinoma. Staining in benign breast lesions was weak and heterogeneous when compared with that seen in most infiltrating carcinomas. In situ carcinomas showed an intermediate pattern of staining. The finding of only small foci of weak positivity for D5 antigen in normal and benign breast disease indicated that there are similarities between the expression of D5 antigen and the presence of oestrogen receptor protein in these tissues. A further similarity was seen with in situ carcinomas, which have been shown to have lower oestrogen receptor content than infiltrating carcinomas and a more heterogeneous staining pattern with D5 than is seen in infiltrating tumours. The importance of these findings remains to be evaluated because the precise nature of D5 antigen and its association with the oestrogen receptor molecule is not fully understood.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835402      PMCID: PMC1141474          DOI: 10.1136/jcp.41.4.448

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue.

Authors:  C J Menendez-Botet; J S Nisselbaum; M Fleisher; P P Rosen; A Fracchia; G Robbins; J A Urban; M K Schwartz
Journal:  Clin Chem       Date:  1976-08       Impact factor: 8.327

2.  Oestrogen receptor activity in intraduct and invasive breast carcinomas.

Authors:  R A Hawkins; A L Tesdale; W A Ferguson; J J Going
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

3.  Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features.

Authors:  C Giani; E D'Amore; J C Delarue; H Mouriesse; F May-Levin; H Sancho-Garnier; M Breccia; G Contesso
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

4.  Estrogen receptor values in patients with benign breast disease.

Authors:  J C Allegra; M E Lippman; L Green; A Barlock; R Simon; E B Thompson; K K Huff; W Griffin
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

5.  Monoclonal antibodies against a component related to soluble estrogen receptor.

Authors:  A I Coffer; K M Lewis; A J Brockas; R J King
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.

Authors:  R J King; A I Coffer; J Gilbert; K Lewis; R Nash; R Millis; S Raju; R W Taylor
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Estradiol and progesterone receptors in human breast fibroadenomas.

Authors:  F Kuttenn; S Fournier; J C Durand; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

8.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

9.  Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: stromal localization of progesterone receptor.

Authors:  B R Rao; J S Meyer; C G Fry
Journal:  Cancer       Date:  1981-04-15       Impact factor: 6.860

10.  Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay.

Authors:  P Feherty; G Farrer-Brown; A E Kellie
Journal:  Br J Cancer       Date:  1971-12       Impact factor: 7.640

View more
  1 in total

1.  A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer.

Authors:  S Love; R J King
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.